Since disregulation of LTO1 and MMS19 contribute to tumorigenesis (2, 38), we inspected the catalogue of somatic mutations in cancer (39) and identified alterations in 6 human genes (SI Appendix, Fig. S13) that would lead to decreased TCR functionality. This evidence concerns the gene MMS19 and cancer.